A comprehensive peptide formulation targeting multiple synergistic domains, creating a regenerative, anabolic, and autoimmune suppression stack for rheumatoid arthritis, tissue repair, and muscle regeneration.
GHRP-2 (Growth Hormone Releasing Peptide-2):
Synthetic ghrelin mimetic binding to GHS-R1a receptor. Stimulates pulsatile GH release via hypothalamic and pituitary pathways, increases IGF-1 production promoting collagen synthesis, cartilage repair, and bone density.
Ipamorelin:
Selective GHS mimetic with minimal cortisol or prolactin stimulation. Binds GHS-R1a to trigger GH release without cortisol side effects, enhances bone turnover, cartilage preservation, and muscle mass.
PEG-MGF (Pegylated Mechano Growth Factor):
Splice variant of IGF-1 induced by injury; PEGylation increases half-life. Promotes myoblast proliferation and muscle repair, stimulates satellite cell activation in muscle and joint tissue.
Thymalin:
Thymus-derived peptide complex regulating immunity and cell differentiation. Balances T-helper subtypes (Th1/Th2/Th17/Treg), normalizes immune tolerance, reducing autoreactivity in RA.
Tesamorelin:
Stabilized GHRH analog resistant to DPP-4 degradation. Stimulates pituitary GH release via GHRH receptor, induces physiological GH profile, raising IGF-1 safely.